Growth Metrics

Pfizer (PFE) Treasury Shares (2016 - 2025)

Pfizer (PFE) has disclosed Treasury Shares for 17 consecutive years, with $115.0 billion as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed 0.22% to $115.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $115.0 billion through Dec 2025, changed 0.22% year-over-year, with the annual reading at $115.0 billion for FY2025, 0.22% changed from the prior year.
  • Treasury Shares for Q4 2025 was $3.9 billion at Pfizer, roughly flat from $3.9 billion in the prior quarter.
  • The five-year high for Treasury Shares was $3.9 billion in Q1 2025, with the low at $39.0 million in Q2 2022.
  • Average Treasury Shares over 5 years is $3.7 billion, with a median of $3.9 billion recorded in 2023.
  • The sharpest move saw Treasury Shares rose 2.34% in 2022, then grew 0.22% in 2025.
  • Over 5 years, Treasury Shares stood at $111.4 billion in 2021, then rose by 2.34% to $114.0 billion in 2022, then rose by 0.45% to $114.5 billion in 2023, then rose by 0.24% to $114.8 billion in 2024, then rose by 0.22% to $115.0 billion in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $115.0 billion, $115.0 billion, and $115.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.